{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:11:48Z","timestamp":1761581508987,"version":"3.37.3"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00213-016-4523-3","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T17:32:47Z","timestamp":1484242367000},"page":"1525-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions"],"prefix":"10.1007","volume":"234","author":[{"given":"Samantha E.","family":"Yohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Alberati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"4523_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0306-4522(99)00004-4","volume":"92","author":"JE Aberman","year":"1999","unstructured":"Aberman JE, Salamone JD (1999) Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience 92:545\u2013552","journal-title":"Neuroscience"},{"key":"4523_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnsys.2011.00085","volume":"5","author":"L Adermark","year":"2011","unstructured":"Adermark L, Clarke RB, Ericson M, S\u00f6derpalm B (2011) Subregion-specific modulation of excitatory input and dopaminergic output in the striatum by tonically activated glycine and GABA(A) receptors. Front Syst Neurosci 5:85. doi: 10.3389\/fnsys.2011.00085","journal-title":"Front Syst Neurosci"},{"issue":"2","key":"4523_CR3","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neuropharm.2011.11.008","volume":"62","author":"D Alberati","year":"2012","unstructured":"Alberati D, Moreau JL, Lengyel J, Hauser N, Mory R, Borroni E, Pinard E, Knoflach F, Schlotterbeck G, Hainzl D, Wettstein JG (2012) Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology 62(2):1152\u20131161","journal-title":"Neuropharmacology"},{"issue":"1-3","key":"4523_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.08.074","volume":"479","author":"C Arag\u00f3n","year":"2003","unstructured":"Arag\u00f3n C, L\u00f3pez-Corcuera B (2003) Structure, function and regulation of glycine neurotransporters. Eur J Pharmacol 479(1-3):249\u2013262","journal-title":"Eur J Pharmacol"},{"key":"4523_CR5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fncel.2013.00184","volume":"7","author":"A Avila","year":"2013","unstructured":"Avila A, Nguyen L, Rigo JM (2013) Glycine receptors and brain development. Front Cell Neurosci 7:184","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"4523_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1037\/a0036299","volume":"123","author":"D Barch","year":"2014","unstructured":"Barch D, Treadway MT, Schoen N (2014) Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol 123(2):387\u2013397","journal-title":"J Abnorm Psychol"},{"issue":"5","key":"4523_CR7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","volume":"38","author":"J Burgdorf","year":"2013","unstructured":"Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR (2013) GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 38(5):729\u2013742","journal-title":"Neuropsychopharmacology"},{"key":"4523_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2015.07.039","volume":"294","author":"J Burgdorf","year":"2015","unstructured":"Burgdorf J, Kroes RA, Zhang XL, Gross AL, Schmidt M, Weiss C, Disterhoft JF, Burch RM, Stanton PK, Moskal JR (2015) Rapastinel (GLYX-13) has therapeutic potential for thetreatment of post-traumatic stress disorder: characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats. Behav Brain Res 294:177\u2013185","journal-title":"Behav Brain Res"},{"key":"4523_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cortex.2015.04.003","volume":"69","author":"TT Chong","year":"2015","unstructured":"Chong TT, Bonnelle V, Manohar S, Veromann KR, Muhammed K, Tofaris GK, Hu M, Husain M (2015) Dopamine enhances willingness to exert effort for reward in Parkinson\u2019s disease. Cortex 69:40\u201346","journal-title":"Cortex"},{"key":"4523_CR10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0091-3057(93)90226-J","volume":"46","author":"MS Cousins","year":"1993","unstructured":"Cousins MS, Sokolowski JD, Salamone JD (1993) Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol Biochem Behav 46:943\u2013951","journal-title":"Pharmacol Biochem Behav"},{"key":"4523_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02247489","volume":"116","author":"MS Cousins","year":"1994","unstructured":"Cousins MS, Wei W, Salamone JD (1994) Pharmacological characterization of performance on a concurrent lever pressing\/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology (Berlin) 116:529\u2013537","journal-title":"Psychopharmacology (Berlin)"},{"key":"4523_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-4328(95)00151-4","volume":"74","author":"MS Cousins","year":"1996","unstructured":"Cousins MS, Atherton A, Turner L, Salamone JD (1996) Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost\/benefit task. Behav Brain Res 74:189\u2013197","journal-title":"Behav Brain Res"},{"issue":"4","key":"4523_CR13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cercor\/bhh147","volume":"15","author":"B Cubelos","year":"2005","unstructured":"Cubelos B, Gim\u00e9nez C, Zafra F (2005) Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb Cortex 15(4):448\u2013459","journal-title":"Cereb Cortex"},{"key":"4523_CR14","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","volume":"30","author":"R Depoortere","year":"2005","unstructured":"Depoortere R, Dargazanli G, Estenne-Bouhtou G et al (2005) Neurochemical, electrophysiological and pharmacological profiles ofthe selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 30:1963\u20131985","journal-title":"Neuropsychopharmacology"},{"key":"4523_CR15","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1038\/npp.2015.325","volume":"40","author":"E Dunayevich","year":"2015","unstructured":"Dunayevich E, Buchanan R, Chen CY, Dietrich J, Sun H, Marder S (2015) M158. Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia. Neuropsychopharmacology 40:S106\u2013S271","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"4523_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","volume":"30","author":"V Eulenburg","year":"2005","unstructured":"Eulenburg V, Armsen W, Betz H, Gomeza J (2005) Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 30(6):325\u2013333","journal-title":"Trends Biochem Sci"},{"key":"4523_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-006-0554-5","volume":"191","author":"AM Farrar","year":"2007","unstructured":"Farrar AM, Pereira M, Velasco F, Hockemeyer J, Muller CE, Salamone JD (2007) Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology 191:579\u2013586","journal-title":"Psychopharmacology"},{"key":"4523_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuroscience.2007.12.034","volume":"152","author":"AM Farrar","year":"2008","unstructured":"Farrar AM, Font L, Pereira M, Mingote S, Bunce JG, Chrobak JJ, Salamone JD (2008) Forebrain circuitry involved in effort-related choice: injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience 152:321\u2013330","journal-title":"Neuroscience"},{"key":"4523_CR19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuroscience.2009.12.056","volume":"166","author":"AM Farrar","year":"2010","unstructured":"Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, M\u00fcller CE, Correa M, Salamone JD (2010) Nucleus accumbens and effort-relatedfunctions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience 166:1056\u20131067","journal-title":"Neuroscience"},{"issue":"3","key":"4523_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/da.22199","volume":"31","author":"M Fava","year":"2014","unstructured":"Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P, Dube S, Thase ME (2014) Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety 31(3):250\u2013257","journal-title":"Depress Anxiety"},{"key":"4523_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2015.04.040","volume":"166","author":"G Fervaha","year":"2015","unstructured":"Fervaha G, Foussias G, Agida O, Remington G (2015) Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Schizophr Res 166:9\u201316","journal-title":"Schizophr Res"},{"key":"4523_CR22","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","volume":"33","author":"SB Floresco","year":"2008","unstructured":"Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33:1966\u20131979","journal-title":"Neuropsychopharmacology"},{"key":"4523_CR23","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1152\/jn.00361.2002","volume":"88","author":"JF Flores-Hern\u00e1ndez","year":"2002","unstructured":"Flores-Hern\u00e1ndez JF, Cepeda C, Hern\u00e1ndez-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine AA (2002) Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. J Neurophysiol 88:3010\u20133020","journal-title":"J Neurophysiol"},{"key":"4523_CR24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-008-1174-z","volume":"199","author":"L Font","year":"2008","unstructured":"Font L, Mingote S, Farrar AM, Pereira M, Worden L, Stopper C, Port RG, Salamone JD (2008) Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology (Berlin) 199:515\u2013526","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1","key":"4523_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2011.06.026","volume":"132","author":"G Foussias","year":"2011","unstructured":"Foussias G, Mann S, Zakzanis KK, van Reekum R, Agid O, Remington G (2011) Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits. Schizophr Res 132(1):24\u201327","journal-title":"Schizophr Res"},{"issue":"5","key":"4523_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.euroneuro.2013.10.017","volume":"24","author":"G Foussias","year":"2014","unstructured":"Foussias G, Agid O, Fervaha G, Remington G (2014) Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol 24(5):693\u2013709","journal-title":"Eur Neuropsychopharmacol"},{"key":"4523_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2004.09.064","volume":"373","author":"L Gabernet","year":"2005","unstructured":"Gabernet L, Pauly-Evers M, Schwerdel C, Lentz M, Bluethmann H, Vogt K, Alberati D, Mohler H, Boison D (2005) Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci Lett 373:79\u201384","journal-title":"Neurosci Lett"},{"issue":"3","key":"4523_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wps.20167","volume":"13","author":"S Galderisi","year":"2014","unstructured":"Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, Rucci P, Gibertoni D, Aguglia E, Amore M, Bellomo A, Biondi M, Brugnoli R, Dell\u2019Osso L, De Ronchi D, Di Emidio G, Di Giannantonio M, Fagiolini A, Marchesi C, Monteleone P, Oldani L, Pinna F, Roncone R, Sacchetti E, Santonastaso P, Siracusano A, Vita A, Zeppegno P, Maj M (2014) The influence of illness-related variables, personal resourcesa nd context-related factors on real-life functioning of people with schizophrenia. World Psychiatr 13(3):275\u2013287","journal-title":"World Psychiatr"},{"issue":"12","key":"4523_CR29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/archgenpsychiatry.2012.652","volume":"69","author":"MF Green","year":"2012","unstructured":"Green MF, Hellemann G, Horan WP, Lee J, Wynn JK (2012) From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry 69(12):1216\u20131224","journal-title":"Arch Gen Psychiatry"},{"key":"4523_CR30","doi-asserted-by":"crossref","unstructured":"Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013) Negative symptoms\u00a0of schizophrenia are associated with abnormal effort-cost computations.\u00a0Biol Psychiatry\u00a074(2):130\u2013136","DOI":"10.1016\/j.biopsych.2012.12.022"},{"key":"4523_CR31","doi-asserted-by":"crossref","unstructured":"Gold JM, Waltz JA, Frank MJ (2015) Effort cost computation in schizophrenia: A commentary on the recent literature. Biol Psychiatry 41(5):1035\u20131044","DOI":"10.1016\/j.biopsych.2015.05.005"},{"key":"4523_CR32","doi-asserted-by":"crossref","unstructured":"Hartmann MN, Hager OM, Reimann AV, Chumbley JR, Kirschner M, Seifritz E, Tobler PN, Kaiser S (2015) Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophr Bull 41(2):503\u2013512","DOI":"10.1093\/schbul\/sbu102"},{"issue":"4","key":"4523_CR33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mds.25306","volume":"28","author":"U Heresco-Levy","year":"2013","unstructured":"Heresco-Levy U, Shoham S, Javitt DC (2013) Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson\u2019s disease: a hypothesis. Mov Disord 28(4):419\u2013424","journal-title":"Mov Disord"},{"key":"4523_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jad.2016.02.003","volume":"196","author":"R Hershenberg","year":"2016","unstructured":"Hershenberg R, Satterthwaite TD, Daldal A, Katchmar N, Moore TM, Kable JW, Wolf DH (2016) Diminished effort on a progressive ratio task in both unipolar and bipolar depression. J Affect Disord 196:97\u2013100","journal-title":"J Affect Disord"},{"key":"4523_CR35","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00213-016-4317-7","volume":"233","author":"C Hofmann","year":"2016","unstructured":"Hofmann C, Pizzagalli F, Boetsch C, Alberati D, Ereshefsky L, Jhee S, Patat A, Boutouyrie-Dumont B, Martin-Facklam M (2016) Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers. Psychopharmacology 233:2429\u20132439","journal-title":"Psychopharmacology"},{"issue":"5","key":"4523_CR36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/schbul\/sbv090","volume":"41","author":"WP Horan","year":"2015","unstructured":"Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF (2015) Effort-based decision-making paradigms for clinical trials in schizophrenia: part 2\u2014external validity and correlates. Schizophr Bull 41(5):1055\u20131065","journal-title":"Schizophr Bull"},{"issue":"4","key":"4523_CR37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/npp.2014.285","volume":"40","author":"JG Hosking","year":"2015","unstructured":"Hosking JG, Floresco SB, Winstanley CA (2015) Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost\/benefit decision-making tasks. Neuropsychopharmacology 40(4):1005\u20131015","journal-title":"Neuropsychopharmacology"},{"key":"4523_CR38","unstructured":"Keppel G (1991) Design and Analysis: A Researcher\u2019s Handbook, 3rd Edition. Prentice-Hall, Englewood Cliffs"},{"issue":"1","key":"4523_CR39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","volume":"56","author":"JW Lynch","year":"2009","unstructured":"Lynch JW (2009) Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56(1):303\u2013309","journal-title":"Neuropharmacology"},{"key":"4523_CR40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","volume":"12","author":"B Mai","year":"2012","unstructured":"Mai B, Sommer S, Hauber W (2012) Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 12:74\u201384","journal-title":"Cogn Affect Behav Neurosci"},{"key":"4523_CR41","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.neubiorev.2013.08.007","volume":"37","author":"A Markou","year":"2013","unstructured":"Markou A, Salamone JD, Bussey T, Mar A, Brunner D, Gilmour G, Balsam P (2013) Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev 37:2149\u20132165","journal-title":"Neurosci Biobehav Rev"},{"issue":"Pt 2","key":"4523_CR42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1113\/jphysiol.2004.063321","volume":"557","author":"M Martina","year":"2004","unstructured":"Martina M, Gorfinke Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R (2004) Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol 557(Pt 2):489\u2013500","journal-title":"J Physiol"},{"key":"4523_CR43","unstructured":"McCarthy JM, Treadway MT, Bennett ME, Blanchard JJ (2016) Inefficient effortallocation and negative symptoms in individuals with schizophrenia. SchizophrRes\u00a0170(2-3):278\u2013284"},{"key":"4523_CR44","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1523\/JNEUROSCI.1525-08.2008","volume":"28","author":"S Mingote","year":"2008","unstructured":"Mingote S, Font L, Farrar AM, Vontell R, Worden LT, Stopper CM, Port RG, Sink KS, Bunce JG, Chrobak JJ, Salamone JD (2008) Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J Neurosci 28:9037\u20139046","journal-title":"J Neurosci"},{"key":"4523_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.ALC.0000150006.17168.F7","volume":"29","author":"A Molander","year":"2005","unstructured":"Molander A, S\u00f6derpalm B (2005) Glycine receptors regulate dopamine release in the rat nucleus accumbens. Alcohol Clin Exp Res 29:17\u201326","journal-title":"Alcohol Clin Exp Res"},{"key":"4523_CR46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-008-1441-z","volume":"204","author":"AM Mott","year":"2009","unstructured":"Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Muller CE, Salamone JD (2009) The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost\/benefit procedure. Psychopharmacology 204:103\u2013112","journal-title":"Psychopharmacology"},{"issue":"1-2","key":"4523_CR47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuropharm.2011.04.010","volume":"61","author":"A Nikiforuk","year":"2011","unstructured":"Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P (2011) Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine\/NMDA receptor-dependent manner. Neuropharmacology 61(1-2):262\u2013267","journal-title":"Neuropharmacology"},{"key":"4523_CR48","doi-asserted-by":"crossref","unstructured":"Nowend KL, Arizzi M, Carlson BB, Salamone JD (2001) D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 69:373\u2013382","DOI":"10.1016\/S0091-3057(01)00524-X"},{"key":"4523_CR49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2010.05.068","volume":"170","author":"EJ Nunes","year":"2010","unstructured":"Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD (2010) Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience 170:268\u2013280","journal-title":"Neuroscience"},{"key":"4523_CR50","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neubiorev.2013.04.002","volume":"37","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD (2013a) Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev 37:2015\u20132025","journal-title":"Neurosci Biobehav Rev"},{"key":"4523_CR51","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn S, Baqi Y, M\u00fcller CE, Lopez-Cruz L, Correa M, Salamone JD (2013b) Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33:19120\u201319130","journal-title":"J Neurosci"},{"key":"4523_CR52","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.neuropharm.2011.12.033","volume":"62","author":"M Pardo","year":"2012","unstructured":"Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, M\u00fcller CE, Salamone JD, Correa M (2012) Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology 62:2068\u20132077","journal-title":"Neuropharmacology"},{"key":"4523_CR53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcp.2004.08.029","volume":"69","author":"L Raiteri","year":"2005","unstructured":"Raiteri L, Stigliani S, Siri A, Passalacqua M, Melloni E, Raiteri M, Bonanno G (2005) Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels. Biochem Pharmacol 69:159\u2013168","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"4523_CR54","doi-asserted-by":"crossref","first-page":"e47934","DOI":"10.1371\/journal.pone.0047934","volume":"7","author":"PA Randall","year":"2012","unstructured":"Randall PA, Pardo M, Nunes EJ, L\u00f3pez Cruz L, Vemuri VK, Makriyannis A, Baqi Y, M\u00fcller CE, Correa M, Salamone JD (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow task: pharmacological studies and role of individual differences. PLoS ONE 7(10):e47934","journal-title":"PLoS ONE"},{"issue":"6","key":"4523_CR55","doi-asserted-by":"crossref","first-page":"e99320","DOI":"10.1371\/journal.pone.0099320","volume":"9","author":"PA Randall","year":"2014","unstructured":"Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, M\u00fcller CE, Correa M, Salamone JD (2014) The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs. PLoS ONE 9(6):e99320","journal-title":"PLoS ONE"},{"issue":"2","key":"4523_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2015","unstructured":"Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M, Rowland M, L\u00f3pez-Cruz L, Correa M, Salamone JD (2015) Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort related motivational symptoms. Int J Neuropsychopharmacol 18(2):1\u201311. doi: 10.1093\/ijnp\/pyu017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"4523_CR57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/schbul\/sbv089","volume":"41","author":"LF Reddy","year":"2015","unstructured":"Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF (2015) Effort-based decision-making paradigms for clinical trials in schizophrenia: part 1\u2014psychometric characteristics of 5 paradigms. Schizophr Bull 41(5):1045\u20131054","journal-title":"Schizophr Bull"},{"key":"4523_CR58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","volume":"137","author":"JD Salamone","year":"2002","unstructured":"Salamone JD, Correa M (2002) Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137:3\u201325","journal-title":"Behav Brain Res"},{"key":"4523_CR59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.appet.2009.07.018","volume":"53","author":"JD Salamone","year":"2009","unstructured":"Salamone JD, Correa M (2009) Dopamine\/adenosine interactions involved in effort-related aspects of food motivation. Appetite 53:422\u2013425","journal-title":"Appetite"},{"key":"4523_CR60","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76:470\u2013485","journal-title":"Neuron"},{"key":"4523_CR61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02245659","volume":"04","author":"JD Salamone","year":"1991","unstructured":"Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991) Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology 04:515\u2013521","journal-title":"Psychopharmacology"},{"key":"4523_CR62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-4328(94)90108-2","volume":"65","author":"JD Salamone","year":"1994","unstructured":"Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost\/benefit procedure. Behav Brain Res 65:221\u2013229","journal-title":"Behav Brain Res"},{"key":"4523_CR63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-001-0994-x","volume":"160","author":"JD Salamone","year":"2002","unstructured":"Salamone JD, Arizzi MN, Sandoval MD, Cervone KM, Aberman JE (2002) Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology (Berlin) 160:371\u2013380","journal-title":"Psychopharmacology (Berlin)"},{"key":"4523_CR64","doi-asserted-by":"crossref","unstructured":"Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461\u2013482","DOI":"10.1007\/s00213-006-0668-9"},{"key":"4523_CR65","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.euroneuro.2014.08.014","volume":"25","author":"JD Salamone","year":"2015","unstructured":"Salamone JD, Koychev I, Correa M, McGuire P (2015) Neurobiological basis of motivational deficits in psychopathology. Eur Neuropsychopharmacol 25:1225\u20131238","journal-title":"Eur Neuropsychopharmacol"},{"key":"4523_CR66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beproc.2016.02.008","volume":"127","author":"JD Salamone","year":"2016","unstructured":"Salamone JD, Correa M, Yohn S, Lopez-Cruz L, San Miguel N, Alatorre L (2016a) The pharmacology of effort-related choice behavior: dopamine, depression, and individual differences. Behav Process 127:3\u201317","journal-title":"Behav Process"},{"issue":"Pt 5","key":"4523_CR67","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/brain\/aww050","volume":"139","author":"JD Salamone","year":"2016","unstructured":"Salamone JD, Yohn S, Lopez-Cruz L, San Miguel N, Correa M (2016b) Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain 139(Pt 5):1325\u20131347","journal-title":"Brain"},{"key":"4523_CR68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/7854_2015_383","volume":"27","author":"JD Salamone","year":"2016","unstructured":"Salamone JD, Pardo M, Yohn SE, Lopez-Cruz L, San Miguel N, Correa M (2016c) Mesolimbic dopamine and the regulation of motivated behavior. Curr Top Behav Neurosci 27:231\u2013257","journal-title":"Curr Top Behav Neurosci"},{"key":"4523_CR69","doi-asserted-by":"crossref","unstructured":"Singer P, Dubroqua S, Yee BK (2015)\u00a0Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy? Curr Pharm Des 21(26):3771\u20133787","DOI":"10.2174\/1381612821666150724100952"},{"issue":"4","key":"4523_CR70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","volume":"196","author":"KS Sink","year":"2008","unstructured":"Sink KS, Vemuri VK, Olszewska T, Makriyannis A, Salamone JD (2008) Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology 196(4):565\u2013574","journal-title":"Psychopharmacology"},{"issue":"6","key":"4523_CR71","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jpsychires.2013.01.015","volume":"47","author":"GP Strauss","year":"2013","unstructured":"Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Green MF, Buchanan RW, Carpenter WT Jr (2013) Deconstructing negative symptoms of schizophrenia: avolition\u2013apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res 47(6):783\u2013790","journal-title":"J Psychiatr Res"},{"key":"4523_CR72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","volume":"35","author":"MT Treadway","year":"2011","unstructured":"Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35:537\u2013555","journal-title":"Neurosci Biobehav Rev"},{"key":"4523_CR73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","volume":"121","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012) Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121:553\u2013558","journal-title":"J Abnorm Psychol"},{"issue":"2-3","key":"4523_CR74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.schres.2014.11.024","volume":"161","author":"MT Treadway","year":"2015","unstructured":"Treadway MT, Peterman JS, Zald DH, Park S (2015) Impaired effort allocation in patients with schizophrenia. Schizophr Res 161(2-3):382\u2013385","journal-title":"Schizophr Res"},{"key":"4523_CR75","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.0402662101","volume":"101","author":"G Tsai","year":"2004","unstructured":"Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT (2004) Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A 101:8485\u20138490","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4523_CR76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pcn.12175","volume":"68","author":"CH Tsai","year":"2014","unstructured":"Tsai CH, Huang HC, Liu BL, Li CI, Lu MK, Chen X, Tsai MC, Yang YW, Lane HY (2014) Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson\u2019s disease with dementia. Psychiatry Clin Neurosci 68(9):692\u2013700","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"4523_CR77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapsychiatry.2014.163","volume":"71","author":"D Umbricht","year":"2013","unstructured":"Umbricht D, Alberati D, Martin-Facklam M, Borroni E, Youssef EA, Ostland M, Wallace TL, Knoflach F, Dorflinger E, Wettstein JG, Bausch A, Garibaldi G, Santarelli L (2013) Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia. JAMA Psychiatr 71(6):637\u2013646","journal-title":"JAMA Psychiatr"},{"key":"4523_CR78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-008-1396-0","volume":"203","author":"LT Worden","year":"2009","unstructured":"Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, Muller CE, Salamone JD (2009) The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology 203:489\u2013499","journal-title":"Psychopharmacology"},{"issue":"3","key":"4523_CR79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pharmthera.2008.08.004","volume":"120","author":"CR Yang","year":"2008","unstructured":"Yang CR, Svensson KA (2008) Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia. Pharmacol Ther 120(3):317\u2013332","journal-title":"Pharmacol Ther"},{"key":"4523_CR80","doi-asserted-by":"crossref","unstructured":"Yang XH, Huang J, Zhu CY, Wang YF, Cheung EF, Chan RC, Xie GR (2014) Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients. Psychiatry Res 220(3):874-882","DOI":"10.1016\/j.psychres.2014.08.056"},{"issue":"7","key":"4523_CR81","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Thompson C, Randall PA, Lee CA, M\u00fcller CE, Baqi Y, Correa M, Salamone JD (2015a) The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232(7):1313\u20131323","journal-title":"Psychopharmacology"},{"key":"4523_CR82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pbb.2015.05.003","volume":"135","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD (2015b) The role of dopamine D1 receptor transmission in effort-related choice behavior: effects of D1 agonists. Pharmacol Biochem Behav 135:217\u2013226","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"4523_CR83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/npp.2015.188","volume":"41","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M, Salamone JD (2016a) Not all antidepressants are created equal: differential effects of monoamine uptake inhibitors on effort-related choice behavior. Neuropsychopharmacology 41(3):686\u2013694","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"4523_CR84","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00213-015-4176-7","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD (2016b) Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology 233(6):949\u2013960","journal-title":"Psychopharmacology"},{"key":"4523_CR85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2016.06.004","volume":"148","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Gogoj A, Haque A, Lopez-Cruz L, Haley A, Huxley P, Baskin P, Correa M, Salamone JD (2016c) Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040. Pharmacol Biochem Behav 148:84\u201391","journal-title":"Pharmacol Biochem Behav"},{"key":"4523_CR86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuropharm.2016.06.018","volume":"109","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Errante EL, Rosenbloom-Snow A, Sommerville M, Rowland MA, Tokarski K, Zafar N, Correa M, Salamone JD (2016d) Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology 109:270\u2013280","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4523-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4523-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4523-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T09:18:42Z","timestamp":1568711922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4523-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":86,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["4523"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4523-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}